This phase of Biopharma product development is typically used for oncology but may have some applications beyond oncology. Phase 0 clinical trials are also useful to understand the broader landscape of what will likely occur / transpire in Phase I trials as a means of preparing for broader / more formal Phase I trials, as there are many parallels irrespective of disease area.